12 results on '"Grover, Shilpa"'
Search Results
2. Tu1146 GERMLINE AND SOMATIC VARIANTS ASSOCIATED WITH IMMUNE-CHECKPOINT INHIBITOR RELATED COLITIS.
3. Su1249: CANCER OUTCOMES IN PATIENTS TREATED WITH BIOLOGICS FOR THE TREATMENT OF STEROID-REFRACTORY IMMUNE CHECKPOINT INHIBITOR COLITIS.
4. Su1246: PREDICTORS OF NEED FOR BIOLOGIC THERAPY IN IMMUNE CHECKPOINT INHIBITOR COLITIS.
5. 236 EFFECT OF CORTICOSTEROID DOSING ON OUTCOMES IN HIGH-GRADE IMMUNE CHECKPOINT INHIBITOR HEPATITIS.
6. 235 LIVER BIOPSY IS OF LIMITED UTILITY IN THE DIAGNOSIS AND MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR HEPATITIS IN CANCER PATIENTS.
7. Sa284 ETIOLOGY AND OUTCOMES OF PANCREATIC ENZYME ELEVATIONS WITH THE USE OF IMMUNE CHECKPOINT INHIBITORS IN ADVANCED CANCERS.
8. Su1949 Comparison of Pathogenic APC and Biallelic MUTYH Mutations Between Ashkenazi Jews and Non-Ashkenazi Jews With Colorectal Adenomas.
9. Hereditary Pancreatic Cancer.
10. S1983 Phenotypic Differences Between APC and Biallelic MUTYH Mutation Carriers in 1193 Individuals With Attenuated Polyposis.
11. M1935 Premm1,2 and Barnetson-MMRpredict Risk Models Have High Sensitivity for Identifying Individuals with Lynch Syndrome.
12. M1928 Prevalence of APC and MYH Mutations Among 2141 Individuals with Greater Than 10 Colorectal Adenomas.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.